BATON ROUGE, La., March 04, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Oppenheimer 30th Annual Healthcare Conference in New York, N.Y. on Tuesday, March 17, 2020. The pr

FORT WORTH, Texas, March 03, 2020 (GLOBE NEWSWIRE) -- CERiS, a division of CorVel Healthcare, and a leading national provider of payment integrity and prospective claims review for health care payers, has appointed insurance industry veteran Mark Johnson as Vice President of Product Management. “Mark’s deep expertise in health care, insurance, and policy is

BRENTWOOD, Tenn., March 02, 2020 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX:DVCR) today announced that it is scheduled to report financial results for its fourth quarter ended December 31, 2019, on Thursday, March 5, 2020, after the market closes.  Diversicare will also hold a conference call at 5:00 p.m. ET, 4:00 p.m. CT, on Thursday

Fourth quarter 2019 revenue of $18.1 million, an increase of 18% compared to the prior year periodFourth quarter 2019 gross margin of 78.3%, an increase of 410 basis points from the prior year periodFourth quarter 2019 net loss of $1.6 million, as comp

EAGLE, Idaho, March 02, 2020 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that a subsidiary of Cornerstone Healthcare, Inc., Pennant’s home health and hospice portfolio company, acquired Hospice of Missoula, an ag

SAN DIEGO, March 02, 2020 (GLOBE NEWSWIRE) -- While chocolate bunnies may be a staple Springtime candy, Doug Disraeli D.D.S. warns that the delicious candy bunnies are at the top of his list of candies to avoid and offers a few tips to having a healthy mouth this Spring. “Milk chocolate bunnies can be problematic because they take several days to

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the Genesis RMN® System for the robotic navigation of magnetic ablation catheters to treat heart rhythm disorders. “Genesis is a leap forward in Robotic Magnetic Navigation technology,” said David Fischel, Chairman and CEO. “We are confident Genesis will have a mea

Magnolia Medical today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of new configurations and the entire Steripath® Gen2 Initial Specimen Diversion Device® product family. Extensive clinical data demonstrating the performance achieved with Steripath was evaluated by the FDA. This data included peer-reviewed controlled studies published in leading medical journals including Clinical Infectious Diseases1 (CID) and the Journal of Emergency Nursing2 (JEN) d

CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease. Aortic arch disease includes both aortic aneurysms and aortic dissections, which occur suddenly and usually without warning. Approximately 7,000 patients are surgically treated for thoracic aortic arch disease annually in Europe, the Middle East and Africa.

TriMed, Inc. an orthopaedic medical device developer and manufacturer focused on extremities, announced it would begin marketing its new ASET™ Foot Plating System. The ASET Foot Plating System, designed to treat common forefoot and mid-foot indications, offers unique implants to treat MTP fusions, Lapidus fusions, and TMT fusions. In addition, the system’s variety of patented Hook Plates provide additional points of fixation to bones of limited real estate without relyin